Franklin Biotechnology Discv A(acc)USD |
Growth Of 1000 (EUR) | 31/03/2024 |
|
Annual Returns (EUR) | 31/03/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 31/03 | |
Total Return | 2.70 | -12.09 | 35.99 | 16.98 | -11.09 | -6.77 | 13.33 | 14.51 |
+/- Category | -3.36 | -3.11 | 8.66 | -2.26 | -8.07 | 6.01 | 12.25 | 10.81 |
+/- Category Index | -8.06 | -9.15 | 12.36 | -8.85 | -18.02 | -3.74 | 3.43 | 4.55 |
% Rank in Category | 74 | 81 | 15 | 30 | 78 | 51 | 12 | 4 |
Trailing Returns (EUR) | 18/04/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | -1.75 | -1.07 | -1.22 |
1 Week | -6.87 | -3.27 | -4.43 |
1 Month | -5.33 | -0.53 | -0.99 |
3 Months | 2.48 | 4.68 | -1.40 |
6 Months | 18.66 | 9.61 | 8.45 |
YTD | 4.86 | 7.57 | -0.33 |
1 Year | 17.01 | 14.60 | 6.50 |
3 Years Annualised | 0.51 | 6.54 | -6.13 |
5 Years Annualised | 6.91 | 1.30 | -4.92 |
10 Years Annualised | 8.29 | -0.88 | -2.88 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (EUR) | 31/03/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 14.51 | - | - | - |
2023 | -1.13 | 0.95 | 1.31 | 12.08 |
2022 | -7.01 | -5.85 | 8.28 | -1.66 |
2021 | -1.07 | -0.39 | -2.85 | -7.13 |
2020 | -11.09 | 25.73 | -1.15 | 5.86 |
2019 | 21.03 | 2.11 | -10.70 | 23.22 |
Advertisement |